plainyogurt21's profile picture. Future MD, Bioengineer, Investor, Member at http://Microcapclub.com, Call Leader @Slingshot_Invst, http://www.subradata.com, http://adus.substack.com

Adu Subramanian

@plainyogurt21

Future MD, Bioengineer, Investor, Member at http://Microcapclub.com, Call Leader @Slingshot_Invst, http://www.subradata.com, http://adus.substack.com

مثبتة

As we approach Q4, here's the catalyst Tracker for any company with active SEC filings. LMK if a company is missing and I can add it. subradata.com/catalyst_data_…

Last couple weeks have been electric. May the thunder roll into Q4 $XBI $BBC Some upcoming catalysts that are on my radar: $JANX PSMA / EGFR Ph1 $AGIO PKR SCD Ph3 $FULC SCD Ph1b $RZLT cHI Ph3 $GOSS PAH Ph3 $ZBIO IgG4-RD Ph3 $IMVT TED Ph3 $PVLA cVM Ph2 $BBIO ADH1 Ph3 / LGMD2i…



$MRK inclusion is >4WU PVR. Different population than $TECX > 2 PVR. 70% greater than 3PVR.

plainyogurt21's tweet image. $MRK inclusion is >4WU PVR. Different population than $TECX > 2 PVR. 70% greater than 3PVR.

PH-HFpEF space heating up 🔥 - $tecx relaxin mimetic ph2 2026 - $tenx levosimendan (inodilator) ph3 2026 - $azn relaxin mimetic ph2 readout 2025 (still waiting) - $mrk activin inhibitor ph2 positive (announced today) / already approved in PAH (group 1 PH), to initiate phase 3…

aditharun_'s tweet image. PH-HFpEF space heating up 🔥

- $tecx relaxin mimetic ph2 2026
- $tenx levosimendan (inodilator) ph3 2026
- $azn relaxin mimetic ph2 readout 2025 (still waiting)
- $mrk activin inhibitor ph2 positive (announced today) / already approved in PAH (group 1 PH), to initiate phase 3…


I think THe FDA stuff is BS. Can't flip flop with this, but on $QURE, I disagree on the NfL validity in this population. We're introducing invasive brain surgery which increases the NfL initially before reducing it at 3 years. We don't know how this NfL changes the dynamics of…

plainyogurt21's tweet image. I think THe FDA stuff is BS. Can't flip flop with this, but on $QURE, I disagree on the NfL validity in this population. We're introducing invasive brain surgery which increases the NfL initially before reducing it at 3 years. We don't know how this NfL changes the dynamics of…
plainyogurt21's tweet image. I think THe FDA stuff is BS. Can't flip flop with this, but on $QURE, I disagree on the NfL validity in this population. We're introducing invasive brain surgery which increases the NfL initially before reducing it at 3 years. We don't know how this NfL changes the dynamics of…

First of all, props to the author of this first time biotech write up on $QURE. It takes a lot of time and courage to put your stuff out there, but it is an unrivaled way to learn. Now, there are several things I disagree with in the article, so I'll do my part and perhaps…



Adu Subramanian أعاد

Here's the PK data I could find out there.

plainyogurt21's tweet image. Here's the PK data I could find out there.
plainyogurt21's tweet image. Here's the PK data I could find out there.

Should everyone be microdosing a GLP1 (once generic/affordable)? IMO willpower required to stay at stable weight would be better spent elsewhere. Plus anti inflammatory effects....


$AGIO functional unblinding may be an interesting factor. It's essentially a blood vitamin for people who lack blood health. Combine that with hemoglobin increases (don't happen on placebo) and patients on drug may know it.....


Turns out 2+2 did indeed equal 4, or put another way….HR .5 $COGT

$COGT 2+2=4 Right?

plainyogurt21's tweet image. $COGT 

2+2=4 

Right?
plainyogurt21's tweet image. $COGT 

2+2=4 

Right?


Hot take: a lot of stuff we do in medicine isn't supported by "perfect" evidence. Sometimes (most of the time), medicine is leaning into the vibes. Hard to believe anyone will run this trial well. And if safe/affordable, what is the downside of microdosing a GLP?

There is no peer-reviewed scientific evidence that shows microdosing GLP-1RA drugs is effective or safe. @theaace does not support the routine use of microdosing GLP-1RA medications in clinical care and recommends adherence to FDA-approved dosing guidelines for these agents.…

scottisaacsmd's tweet image. There is no peer-reviewed scientific evidence that shows microdosing GLP-1RA drugs is effective or safe. @theaace does not support the routine use of microdosing GLP-1RA medications in clinical care and recommends adherence to FDA-approved dosing guidelines for these agents.…


$TECX still no news from $AZN results supposedly 2h25 for re phire Azd 3427


$QURE I completely understand the concerns on the dataset (in fact I raised these exact concerns before it was released x.com/plainyogurt21/…, x.com/plainyogurt21/… but the problem is two fold 1) you can't design a trial to hit prior endpoints if the FDA changes the…

I know the answer: it didn't change. They pivoted from using the biomarker and no longer show it. THERE IS NO HUMAN EVIDENCE OF TARGET ENGAGEMENT in the HIGH DOSE cohort. not saying it won't work.....but to say we have human evidence is wrong

plainyogurt21's tweet image. I know the answer: it didn't change. They pivoted from using the biomarker and no longer show it. THERE IS NO  HUMAN EVIDENCE OF TARGET ENGAGEMENT in the HIGH DOSE cohort. 

not saying it won't work.....but to say we have human evidence is wrong
plainyogurt21's tweet image. I know the answer: it didn't change. They pivoted from using the biomarker and no longer show it. THERE IS NO  HUMAN EVIDENCE OF TARGET ENGAGEMENT in the HIGH DOSE cohort. 

not saying it won't work.....but to say we have human evidence is wrong


Loading...

Something went wrong.


Something went wrong.